drugset / Trial / NCT05688111

Tranexamic Acid as an Intervention in Placenta Previa

NCT05688111

Completed 146 enrolled Hawler Medical University
RandomizedParallel-groupTriple-blindTreatment

Summary

Antepartum hemorrhage (APH) due to placenta previa is an important cause of worldwide perinatal mortality and maternal morbidity in pregnant women

Timeline

Start
2022-12-10
Primary completion
2023-12-03
Completion
2023-12-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications